Skip to main content

We are excited to be attending Bio Europe 2024 in Stockholm from November 4-6. Our team, represented by Business Development Associate Directors Monica Delgado and João Madeira do Ó, will be at Booth 25, ready to share how AGC Pharma Chemicals can help bring your Small Molecule APIs from early development to commercial-scale production. 

Bio Europe is a leading life sciences partnering event that attracts a wide range of professionals, from biotech and pharmaceutical companies to investors and academic innovators. The event focuses on hot topics and the latest advancements in biotechnology and pharmaceuticals. This makes it an ideal platform for networking, exploring collaborations, and discussing cutting-edge developments. 

 Stop by our booth 25 to discover how our flexible and innovative approaches can enhance your project’s efficiency and success. We look forward to meeting you in Stockholm! 

Latest News

Events & ConventionsAGC Pharma Chemicals to Attend CPHI Japan 2026
8th April 2026

AGC Pharma Chemicals to Attend CPHI Japan 2026

Meet AGC Pharma Chemicals at CPHI Frankfurt 2025, Booth 6.0B44. Discover how we deliver top pharma quality through our CDMO services for APIs and HPAPIs.
Events & ConventionsAGC Pharma Chemicals Honored in Four Categories at the CDMO Leadership Awards 2026
31st March 2026

AGC Pharma Chemicals Honored in Four Categories at the CDMO Leadership Awards 2026

Best in Class distinctions for Overall Staff, Cultural Fit, Technology Use, and Scaling Support. Recognition within the Small/Mid-Size Small Molecule API group. Barcelona, March 30, 2026 – AGC Pharma Chemicals has…
How Reactors Work in a CDMO for Small Molecule APIsAll of ArticlesCDMO ProcessesCDMO TechnologyHow Reactors Work in a CDMO for Small Molecule APIs
13th March 2026

How Reactors Work in a CDMO for Small Molecule APIs

In a pharmaceutical Contract Development and Manufacturing Organization (CDMO), reactors are the foundational equipment where chemical reactions convert raw materials into intermediates and Active Pharmaceutical Ingredients (APIs) under tightly controlled…